Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drospirenone and Ethinyl Estradiol Alone or With Myo-inositol in PCOS
NCT01511822Phase 4Completed
- Sponsor
- AGUNCO Obstetrics and Gynecology Centre
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of myo-inositol in polycystic ovary syndrome (PCOS), insulin resistance (IR), sponsored by AGUNCO Obstetrics and Gynecology Centre. Status: completed.
02
Drugs
myo-inositol
03
Conditions
polycystic ovary syndrome (PCOS)insulin resistance (IR)
Beyond the preview
Go deeper on NCT01511822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511822.